Nature medicine, ISSN 1078-8956, 2015, Volume 21, Issue 11, pp. 1350 - 1356
Colorectal cancer (CRC) is a frequently lethal disease with heterogeneous outcomes and drug responses. To resolve inconsistencies among the reported gene...
MEDICINE, RESEARCH & EXPERIMENTAL | CELLS | III COLON-CANCER | MICROSATELLITE INSTABILITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | PHENOTYPE | CLASSIFICATION | TUMORS | CELL BIOLOGY | RESPONSES | RECTAL-CANCER | MUTATION | GROWTH | ras Proteins - genetics | Microsatellite Instability | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Gene Expression Regulation, Neoplastic | Gene Expression Profiling | Information Dissemination | Neovascularization, Pathologic - pathology | DNA Methylation | Carcinoma - pathology | Proto-Oncogene Proteins - genetics | Colorectal Neoplasms - classification | DNA Copy Number Variations - genetics | Mutation - genetics | Consensus | Phenotype | Transforming Growth Factor beta - genetics | Wnt Signaling Pathway - genetics | Proto-Oncogene Proteins B-raf - genetics | Genes, myc - genetics | CpG Islands | Carcinoma - genetics | Neovascularization, Pathologic - genetics | Carcinoma - classification | Colorectal Neoplasms - pathology | Care and treatment | Usage | MicroRNA | Colorectal cancer | Liquid chromatography | Research | Gene expression | Transforming growth factors | Genotype & phenotype | Genomics | Classificació de tumors | Oncologia | Oncology | Càncer colorectal | Tumors classification
MEDICINE, RESEARCH & EXPERIMENTAL | CELLS | III COLON-CANCER | MICROSATELLITE INSTABILITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | PHENOTYPE | CLASSIFICATION | TUMORS | CELL BIOLOGY | RESPONSES | RECTAL-CANCER | MUTATION | GROWTH | ras Proteins - genetics | Microsatellite Instability | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Gene Expression Regulation, Neoplastic | Gene Expression Profiling | Information Dissemination | Neovascularization, Pathologic - pathology | DNA Methylation | Carcinoma - pathology | Proto-Oncogene Proteins - genetics | Colorectal Neoplasms - classification | DNA Copy Number Variations - genetics | Mutation - genetics | Consensus | Phenotype | Transforming Growth Factor beta - genetics | Wnt Signaling Pathway - genetics | Proto-Oncogene Proteins B-raf - genetics | Genes, myc - genetics | CpG Islands | Carcinoma - genetics | Neovascularization, Pathologic - genetics | Carcinoma - classification | Colorectal Neoplasms - pathology | Care and treatment | Usage | MicroRNA | Colorectal cancer | Liquid chromatography | Research | Gene expression | Transforming growth factors | Genotype & phenotype | Genomics | Classificació de tumors | Oncologia | Oncology | Càncer colorectal | Tumors classification
Journal Article
2.
Full Text
Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
Journal of Clinical Oncology, ISSN 0732-183X, 01/2010, Volume 28, Issue 2, pp. 245 - 255
Purpose We investigated the global gene expression in a large panel of pancreatic endocrine tumors (PETs) aimed at identifying new potential targets for...
RAD001 EVEROLIMUS | HOMOLOGOUS FACTORS | SOMATOSTATIN ANALOG | SUPPRESSOR GENE | ONCOLOGY | CYCLIN D1 | PROTEIN-KINASE | GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS | GENE-EXPRESSION | THERAPEUTIC TARGETS | TUBEROUS SCLEROSIS | PTEN Phosphohydrolase - genetics | Signal Transduction | Down-Regulation | Humans | Middle Aged | Male | Pancreatic Neoplasms - genetics | Gene Expression Profiling | Proto-Oncogene Proteins c-akt - genetics | Neoplasm Metastasis | Tumor Suppressor Proteins - genetics | Adolescent | Carcinoma, Islet Cell - genetics | Cell Line, Tumor | Adult | Female | Aged | To4 | Endo7 | ORIGINAL REPORTS | Gic28
RAD001 EVEROLIMUS | HOMOLOGOUS FACTORS | SOMATOSTATIN ANALOG | SUPPRESSOR GENE | ONCOLOGY | CYCLIN D1 | PROTEIN-KINASE | GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS | GENE-EXPRESSION | THERAPEUTIC TARGETS | TUBEROUS SCLEROSIS | PTEN Phosphohydrolase - genetics | Signal Transduction | Down-Regulation | Humans | Middle Aged | Male | Pancreatic Neoplasms - genetics | Gene Expression Profiling | Proto-Oncogene Proteins c-akt - genetics | Neoplasm Metastasis | Tumor Suppressor Proteins - genetics | Adolescent | Carcinoma, Islet Cell - genetics | Cell Line, Tumor | Adult | Female | Aged | To4 | Endo7 | ORIGINAL REPORTS | Gic28
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 13, pp. 2151 - 2158
Purpose To determine whether the clinical and molecular biologic characteristics of the alveolar rhabdomyosarcoma (ARMS) and embryonal rhabdomyosarcoma (ERMS)...
INTERNATIONAL-SOCIETY | PROGNOSTIC-FACTORS | ONCOLOGY | PAX3-FKHR | ARRAY-CGH | NONMETASTATIC RHABDOMYOSARCOMA | INTERGROUP-RHABDOMYOSARCOMA | CLASSIFICATION | CHILDHOOD | CHILDRENS ONCOLOGY GROUP | PEDIATRIC-ONCOLOGY | Paired Box Transcription Factors - genetics | Predictive Value of Tests | Genetic Testing | Humans | Gene Expression Regulation, Neoplastic | Child, Preschool | PAX7 Transcription Factor - genetics | Male | Rhabdomyosarcoma, Embryonal - diagnosis | Gene Expression Profiling | Rhabdomyosarcoma, Embryonal - genetics | Nuclear Receptor Coactivator 1 - genetics | Rhabdomyosarcoma, Alveolar - diagnosis | Rhabdomyosarcoma, Alveolar - therapy | Time Factors | Rhabdomyosarcoma, Alveolar - mortality | Rhabdomyosarcoma, Embryonal - therapy | Female | Rhabdomyosarcoma, Alveolar - pathology | France | Child | Rhabdomyosarcoma, Embryonal - pathology | Diagnosis, Differential | PAX3 Transcription Factor | Rhabdomyosarcoma, Alveolar - genetics | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | United Kingdom | Chromosomes, Human, Pair 8 | Rhabdomyosarcoma, Embryonal - mortality | Reverse Transcriptase Polymerase Chain Reaction | Disease-Free Survival | Oncogene Proteins, Fusion - genetics
INTERNATIONAL-SOCIETY | PROGNOSTIC-FACTORS | ONCOLOGY | PAX3-FKHR | ARRAY-CGH | NONMETASTATIC RHABDOMYOSARCOMA | INTERGROUP-RHABDOMYOSARCOMA | CLASSIFICATION | CHILDHOOD | CHILDRENS ONCOLOGY GROUP | PEDIATRIC-ONCOLOGY | Paired Box Transcription Factors - genetics | Predictive Value of Tests | Genetic Testing | Humans | Gene Expression Regulation, Neoplastic | Child, Preschool | PAX7 Transcription Factor - genetics | Male | Rhabdomyosarcoma, Embryonal - diagnosis | Gene Expression Profiling | Rhabdomyosarcoma, Embryonal - genetics | Nuclear Receptor Coactivator 1 - genetics | Rhabdomyosarcoma, Alveolar - diagnosis | Rhabdomyosarcoma, Alveolar - therapy | Time Factors | Rhabdomyosarcoma, Alveolar - mortality | Rhabdomyosarcoma, Embryonal - therapy | Female | Rhabdomyosarcoma, Alveolar - pathology | France | Child | Rhabdomyosarcoma, Embryonal - pathology | Diagnosis, Differential | PAX3 Transcription Factor | Rhabdomyosarcoma, Alveolar - genetics | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | United Kingdom | Chromosomes, Human, Pair 8 | Rhabdomyosarcoma, Embryonal - mortality | Reverse Transcriptase Polymerase Chain Reaction | Disease-Free Survival | Oncogene Proteins, Fusion - genetics
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2012, Volume 30, Issue 14, pp. 1670 - 1677
Purpose To improve the risk stratification of patients with rhabdomyosarcoma (RMS) through the use of clinical and molecular biologic data. Patients and...
STUDY-IV | ONCOLOGY | PAX | NONMETASTATIC RHABDOMYOSARCOMA | CLASSIFICATION | ADVERSE PROGNOSIS | STUDY-III | EXPRESSION | NEGATIVE ALVEOLAR RHABDOMYOSARCOMA | PREDICTION | Paired Box Transcription Factors - genetics | Multivariate Analysis | Translocation, Genetic | Prognosis | Humans | Gene Expression Regulation, Neoplastic | Child, Preschool | Male | Gene Expression Profiling | Risk Management | Forkhead Transcription Factors - metabolism | Neoplasm Invasiveness - pathology | Sensitivity and Specificity | Female | Retrospective Studies | Child | Rhabdomyosarcoma - mortality | Databases, Factual | PAX3 Transcription Factor | Kaplan-Meier Estimate | Proportional Hazards Models | United Kingdom | Forkhead Transcription Factors - genetics | Gene Fusion - genetics | Adolescent | Survival Analysis | Biomarkers, Tumor - genetics | Forkhead Box Protein O1 | Rhabdomyosarcoma - genetics | Neoplasm Staging | Rhabdomyosarcoma - therapy | Paired Box Transcription Factors - metabolism | Cohort Studies
STUDY-IV | ONCOLOGY | PAX | NONMETASTATIC RHABDOMYOSARCOMA | CLASSIFICATION | ADVERSE PROGNOSIS | STUDY-III | EXPRESSION | NEGATIVE ALVEOLAR RHABDOMYOSARCOMA | PREDICTION | Paired Box Transcription Factors - genetics | Multivariate Analysis | Translocation, Genetic | Prognosis | Humans | Gene Expression Regulation, Neoplastic | Child, Preschool | Male | Gene Expression Profiling | Risk Management | Forkhead Transcription Factors - metabolism | Neoplasm Invasiveness - pathology | Sensitivity and Specificity | Female | Retrospective Studies | Child | Rhabdomyosarcoma - mortality | Databases, Factual | PAX3 Transcription Factor | Kaplan-Meier Estimate | Proportional Hazards Models | United Kingdom | Forkhead Transcription Factors - genetics | Gene Fusion - genetics | Adolescent | Survival Analysis | Biomarkers, Tumor - genetics | Forkhead Box Protein O1 | Rhabdomyosarcoma - genetics | Neoplasm Staging | Rhabdomyosarcoma - therapy | Paired Box Transcription Factors - metabolism | Cohort Studies
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2006, Volume 24, Issue 29, pp. 4677 - 4684
Purpose We investigated the global microRNA expression patterns in normal pancreas, pancreatic endocrine tumors and acinar carcinomas to evaluate their...
MOLECULAR-GENETICS | APOPTOSIS | GLIOBLASTOMA | ONCOLOGY | B-CELL LYMPHOMAS | MALIGNANT INSULINOMA | MIRNAS | HUMAN CANCERS | ACCUMULATION | CARCINOMA | PROGRESSION | Prognosis | Pancreatic Neoplasms - diagnosis | Humans | Pancreatic Neoplasms - pathology | Carcinoma, Acinar Cell - pathology | Insulinoma - genetics | MicroRNAs - metabolism | Pancreatic Neoplasms - genetics | Carcinoma, Acinar Cell - genetics | Gene Expression Profiling | Pancreas - metabolism | Survival | Insulinoma - diagnosis | Carcinoma, Acinar Cell - diagnosis | Cell Transformation, Neoplastic | Insulinoma - pathology | Liver Neoplasms - secondary
MOLECULAR-GENETICS | APOPTOSIS | GLIOBLASTOMA | ONCOLOGY | B-CELL LYMPHOMAS | MALIGNANT INSULINOMA | MIRNAS | HUMAN CANCERS | ACCUMULATION | CARCINOMA | PROGRESSION | Prognosis | Pancreatic Neoplasms - diagnosis | Humans | Pancreatic Neoplasms - pathology | Carcinoma, Acinar Cell - pathology | Insulinoma - genetics | MicroRNAs - metabolism | Pancreatic Neoplasms - genetics | Carcinoma, Acinar Cell - genetics | Gene Expression Profiling | Pancreas - metabolism | Survival | Insulinoma - diagnosis | Carcinoma, Acinar Cell - diagnosis | Cell Transformation, Neoplastic | Insulinoma - pathology | Liver Neoplasms - secondary
Journal Article
Nature Communications, ISSN 2041-1723, 09/2016, Volume 7, Issue 1, p. 12602
Enteropathy-associated T-cell lymphoma (EATL), a rare and aggressive intestinal malignancy of intraepithelial T lymphocytes, comprises two disease variants...
EPIGENETIC REGULATORS | STAT3 MUTATIONS | PROTEIN STABILITY | NK CELLS | MULTIDISCIPLINARY SCIENCES | ACUTE LYMPHOBLASTIC-LEUKEMIA | GENES | GAMMA-DELTA-T | CANCER | SOMATIC MUTATIONS | WEB SERVER | Genetic Predisposition to Disease | Histone-Lysine N-Methyltransferase - genetics | Enteropathy-Associated T-Cell Lymphoma - genetics | Intestinal Neoplasms - classification | Genomics | Humans | Mutation | Enteropathy-Associated T-Cell Lymphoma - classification | Gene Expression Regulation, Neoplastic - physiology | Intestinal Neoplasms - genetics
EPIGENETIC REGULATORS | STAT3 MUTATIONS | PROTEIN STABILITY | NK CELLS | MULTIDISCIPLINARY SCIENCES | ACUTE LYMPHOBLASTIC-LEUKEMIA | GENES | GAMMA-DELTA-T | CANCER | SOMATIC MUTATIONS | WEB SERVER | Genetic Predisposition to Disease | Histone-Lysine N-Methyltransferase - genetics | Enteropathy-Associated T-Cell Lymphoma - genetics | Intestinal Neoplasms - classification | Genomics | Humans | Mutation | Enteropathy-Associated T-Cell Lymphoma - classification | Gene Expression Regulation, Neoplastic - physiology | Intestinal Neoplasms - genetics
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2017, Volume 23, Issue 1, pp. 104 - 115
Purpose: Mutation of BRAF at the valine 600 residue occurs in approximately 10% of colorectal cancers, a group with particularly poor prognosis. The response...
COLON-CANCER | MOLECULAR SUBTYPES | CETUXIMAB | INHIBITION | ONCOLOGY | BRAF MUTATION | MICROSATELLITE INSTABILITY | IRINOTECAN | CLASSIFICATION | KRAS WILD-TYPE | BRAF(V600E) | Prognosis | Colorectal Neoplasms - genetics | Humans | Gene Expression Regulation, Neoplastic | Gene Expression Profiling | Biomarkers, Tumor | Colorectal Neoplasms - diagnosis | DNA Methylation | Neoplasm Metastasis | Codon | Proteomics - methods | Colorectal Neoplasms - metabolism | Proto-Oncogene Proteins B-raf - metabolism | Colorectal Neoplasms - mortality | Computational Biology - methods | Gene Expression | Signal Transduction | Kaplan-Meier Estimate | Workflow | Models, Biological | Proto-Oncogene Proteins B-raf - genetics | Mutation | Neoplasm Staging | Amino Acid Substitution | Cluster Analysis | Cohort Studies | TOR protein | Phosphorylation | Deregulation | Epidermal growth factor receptors | Colorectal carcinoma | Colorectal cancer | AKT protein | Biology | Cyclin D1 | Gene expression | Clustering | Patients | Subgroups | K-Ras protein | 1-Phosphatidylinositol 3-kinase | Experimental design | Valine | Proteomics | Cell cycle | Cancer
COLON-CANCER | MOLECULAR SUBTYPES | CETUXIMAB | INHIBITION | ONCOLOGY | BRAF MUTATION | MICROSATELLITE INSTABILITY | IRINOTECAN | CLASSIFICATION | KRAS WILD-TYPE | BRAF(V600E) | Prognosis | Colorectal Neoplasms - genetics | Humans | Gene Expression Regulation, Neoplastic | Gene Expression Profiling | Biomarkers, Tumor | Colorectal Neoplasms - diagnosis | DNA Methylation | Neoplasm Metastasis | Codon | Proteomics - methods | Colorectal Neoplasms - metabolism | Proto-Oncogene Proteins B-raf - metabolism | Colorectal Neoplasms - mortality | Computational Biology - methods | Gene Expression | Signal Transduction | Kaplan-Meier Estimate | Workflow | Models, Biological | Proto-Oncogene Proteins B-raf - genetics | Mutation | Neoplasm Staging | Amino Acid Substitution | Cluster Analysis | Cohort Studies | TOR protein | Phosphorylation | Deregulation | Epidermal growth factor receptors | Colorectal carcinoma | Colorectal cancer | AKT protein | Biology | Cyclin D1 | Gene expression | Clustering | Patients | Subgroups | K-Ras protein | 1-Phosphatidylinositol 3-kinase | Experimental design | Valine | Proteomics | Cell cycle | Cancer
Journal Article
Virchows Archiv, ISSN 0945-6317, 10/2018, Volume 473, Issue 4, pp. 505 - 511
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00428-018-2352-y
Medicine & Public Health | Pathology | LEUKEMIA | PATHOLOGY | Immunohistochemistry | Lymphoma, Large-Cell, Anaplastic - therapy | Phosphorylation | Biomarkers, Tumor - analysis | Breast Implantation - instrumentation | Breast Implants - adverse effects | Humans | In Situ Hybridization, Fluorescence | STAT3 Transcription Factor - analysis | Lymphoma, Large-Cell, Anaplastic - enzymology | Positron Emission Tomography Computed Tomography | Breast Implantation - adverse effects | Janus Kinase 1 - genetics | Female | Aged | Biomarkers, Tumor - genetics | Lymphoma, Large-Cell, Anaplastic - pathology | Mutation | STAT3 Transcription Factor - genetics | Lymphoma, Large-Cell, Anaplastic - genetics | Lymphomas | Genetic aspects | Implants, Artificial | Prosthesis | Janus kinase | Anaplastic large-cell lymphoma | Lymphoma | Stat3 protein
Medicine & Public Health | Pathology | LEUKEMIA | PATHOLOGY | Immunohistochemistry | Lymphoma, Large-Cell, Anaplastic - therapy | Phosphorylation | Biomarkers, Tumor - analysis | Breast Implantation - instrumentation | Breast Implants - adverse effects | Humans | In Situ Hybridization, Fluorescence | STAT3 Transcription Factor - analysis | Lymphoma, Large-Cell, Anaplastic - enzymology | Positron Emission Tomography Computed Tomography | Breast Implantation - adverse effects | Janus Kinase 1 - genetics | Female | Aged | Biomarkers, Tumor - genetics | Lymphoma, Large-Cell, Anaplastic - pathology | Mutation | STAT3 Transcription Factor - genetics | Lymphoma, Large-Cell, Anaplastic - genetics | Lymphomas | Genetic aspects | Implants, Artificial | Prosthesis | Janus kinase | Anaplastic large-cell lymphoma | Lymphoma | Stat3 protein
Journal Article
Oncogene, ISSN 0950-9232, 02/2014, Volume 33, Issue 9, pp. 1148 - 1157
Rhabdomyosarcomas (RMS) are the most frequent soft-tissue sarcoma in children and characteristically show features of developing skeletal muscle. The alveolar...
histone methylation | polycomb repressive complex 2 | PAX3-FOXO1 | JARID2 | rhabdomyosarcoma | myogenic differentiation | BIOCHEMISTRY & MOLECULAR BIOLOGY | 13-CIS-RETINOIC ACID | HISTONE DEMETHYLASES | CHILDRENS ONCOLOGY GROUP | CARDIAC DEVELOPMENT | CELL BIOLOGY | ONCOLOGY | GENETICS & HEREDITY | GENE-EXPRESSION | ALVEOLAR RHABDOMYOSARCOMA | HIGH-RISK NEUROBLASTOMA | TRANSCRIPTION FACTOR | REPRESSIVE COMPLEX 2 | MUSCLE STEM-CELLS | Paired Box Transcription Factors - genetics | Oncogene Proteins, Fusion - metabolism | Cell Proliferation | Polycomb Repressive Complex 2 - genetics | Humans | Rhabdomyosarcoma - pathology | Myogenin - genetics | Histone Demethylases - genetics | Promoter Regions, Genetic - genetics | Cell Differentiation - genetics | Tumor Suppressor Proteins - genetics | Nuclear Proteins - genetics | Gene Expression Regulation, Neoplastic - genetics | Tumor Suppressor Proteins - metabolism | Nuclear Proteins - metabolism | Transcription Factors - genetics | Enhancer of Zeste Homolog 2 Protein | Transcription Factors - metabolism | Histone Demethylases - metabolism | Oncogene Proteins, Fusion - genetics | Cell Line, Tumor | Muscle Development - genetics | Rhabdomyosarcoma - genetics | Transcription, Genetic - genetics | Polycomb Repressive Complex 2 - metabolism | Myogenin - metabolism | Paired Box Transcription Factors - metabolism | Promyelocytic Leukemia Protein | Transcriptional coactivators | Care and treatment | Oncology, Experimental | Rhabdomyosarcoma | Physiological aspects | Histones | Development and progression | Research | Cell differentiation | Carcinogenesis | Cancer | DNA methylation | Pediatrics | Chromatin | Gene expression | Cancer therapies | Polycomb Repressive Complex 2
histone methylation | polycomb repressive complex 2 | PAX3-FOXO1 | JARID2 | rhabdomyosarcoma | myogenic differentiation | BIOCHEMISTRY & MOLECULAR BIOLOGY | 13-CIS-RETINOIC ACID | HISTONE DEMETHYLASES | CHILDRENS ONCOLOGY GROUP | CARDIAC DEVELOPMENT | CELL BIOLOGY | ONCOLOGY | GENETICS & HEREDITY | GENE-EXPRESSION | ALVEOLAR RHABDOMYOSARCOMA | HIGH-RISK NEUROBLASTOMA | TRANSCRIPTION FACTOR | REPRESSIVE COMPLEX 2 | MUSCLE STEM-CELLS | Paired Box Transcription Factors - genetics | Oncogene Proteins, Fusion - metabolism | Cell Proliferation | Polycomb Repressive Complex 2 - genetics | Humans | Rhabdomyosarcoma - pathology | Myogenin - genetics | Histone Demethylases - genetics | Promoter Regions, Genetic - genetics | Cell Differentiation - genetics | Tumor Suppressor Proteins - genetics | Nuclear Proteins - genetics | Gene Expression Regulation, Neoplastic - genetics | Tumor Suppressor Proteins - metabolism | Nuclear Proteins - metabolism | Transcription Factors - genetics | Enhancer of Zeste Homolog 2 Protein | Transcription Factors - metabolism | Histone Demethylases - metabolism | Oncogene Proteins, Fusion - genetics | Cell Line, Tumor | Muscle Development - genetics | Rhabdomyosarcoma - genetics | Transcription, Genetic - genetics | Polycomb Repressive Complex 2 - metabolism | Myogenin - metabolism | Paired Box Transcription Factors - metabolism | Promyelocytic Leukemia Protein | Transcriptional coactivators | Care and treatment | Oncology, Experimental | Rhabdomyosarcoma | Physiological aspects | Histones | Development and progression | Research | Cell differentiation | Carcinogenesis | Cancer | DNA methylation | Pediatrics | Chromatin | Gene expression | Cancer therapies | Polycomb Repressive Complex 2
Journal Article
Cancer Letters, ISSN 0304-3835, 2016, Volume 385, pp. 251 - 260
Abstract Rhabdomyosarcomas (RMS) in children and adolescents are heterogeneous sarcomas broadly defined by skeletal muscle features and the presence/absence of...
Hematology, Oncology and Palliative Medicine | Co-expression modules | Fusion protein | Next generation sequencing | MicroRNAs | Rhabdomyosarcoma | PRIMARY TUMORS | MUSCLE-SPECIFIC MICRORNA | DOWN-REGULATION | FUSION GENE | PEDIATRIC RHABDOMYOSARCOMA | SKELETAL-MUSCLE | ONCOLOGY | EMBRYONAL RHABDOMYOSARCOMA | ALVEOLAR RHABDOMYOSARCOMA | BINDING-SITES | EXPRESSION SIGNATURE | Paired Box Transcription Factors - genetics | Oncogene Proteins, Fusion - metabolism | Humans | Gene Expression Regulation, Neoplastic | Databases, Genetic | MicroRNAs - metabolism | Gene Regulatory Networks | Rhabdomyosarcoma, Embryonal - genetics | Transfection | Rhabdomyosarcoma, Alveolar - metabolism | Biomarkers, Tumor - metabolism | Rhabdomyosarcoma, Alveolar - pathology | Rhabdomyosarcoma, Embryonal - pathology | Genetic Predisposition to Disease | Reproducibility of Results | Rhabdomyosarcoma, Alveolar - genetics | Neoplasm Invasiveness | Computational Biology | Gene Expression Profiling - methods | Gene Fusion | Phenotype | Rhabdomyosarcoma, Embryonal - metabolism | Oncogene Proteins, Fusion - genetics | Cell Line, Tumor | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | MicroRNAs - genetics | Paired Box Transcription Factors - metabolism | Cell Movement | MicroRNA | Sarcoma | Genes | Genetic research | Muscles | Metastasis | Gene expression | Cytokines | Leukemia | Genomes | Roles | Inflammation | Metabolism | Muscle contraction | Cell adhesion & migration | Children & youth | Proteins | Morphogenesis | Signal transduction | Musculoskeletal system | Cell cycle | Cytoskeleton | Extracellular matrix | Software | Localization | Systems development | Deoxyribonucleic acid--DNA | Cancer | RMS, rhabdomyosarcoma | MiRNAs, microRNAs | Original
Hematology, Oncology and Palliative Medicine | Co-expression modules | Fusion protein | Next generation sequencing | MicroRNAs | Rhabdomyosarcoma | PRIMARY TUMORS | MUSCLE-SPECIFIC MICRORNA | DOWN-REGULATION | FUSION GENE | PEDIATRIC RHABDOMYOSARCOMA | SKELETAL-MUSCLE | ONCOLOGY | EMBRYONAL RHABDOMYOSARCOMA | ALVEOLAR RHABDOMYOSARCOMA | BINDING-SITES | EXPRESSION SIGNATURE | Paired Box Transcription Factors - genetics | Oncogene Proteins, Fusion - metabolism | Humans | Gene Expression Regulation, Neoplastic | Databases, Genetic | MicroRNAs - metabolism | Gene Regulatory Networks | Rhabdomyosarcoma, Embryonal - genetics | Transfection | Rhabdomyosarcoma, Alveolar - metabolism | Biomarkers, Tumor - metabolism | Rhabdomyosarcoma, Alveolar - pathology | Rhabdomyosarcoma, Embryonal - pathology | Genetic Predisposition to Disease | Reproducibility of Results | Rhabdomyosarcoma, Alveolar - genetics | Neoplasm Invasiveness | Computational Biology | Gene Expression Profiling - methods | Gene Fusion | Phenotype | Rhabdomyosarcoma, Embryonal - metabolism | Oncogene Proteins, Fusion - genetics | Cell Line, Tumor | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | MicroRNAs - genetics | Paired Box Transcription Factors - metabolism | Cell Movement | MicroRNA | Sarcoma | Genes | Genetic research | Muscles | Metastasis | Gene expression | Cytokines | Leukemia | Genomes | Roles | Inflammation | Metabolism | Muscle contraction | Cell adhesion & migration | Children & youth | Proteins | Morphogenesis | Signal transduction | Musculoskeletal system | Cell cycle | Cytoskeleton | Extracellular matrix | Software | Localization | Systems development | Deoxyribonucleic acid--DNA | Cancer | RMS, rhabdomyosarcoma | MiRNAs, microRNAs | Original
Journal Article
Virchows Archiv, ISSN 0945-6317, 12/2019, Volume 475, Issue 6, pp. 789 - 794
Acinar cell carcinomas (ACCs) of the pancreas are a heterogeneous group of neoplasms showing a wide spectrum of morphological features including acinar, solid,...
Pathology | Acinar cell carcinoma | Thyroid-like | Medicine & Public Health | Morphology | Differential diagnosis | Pancreas | β-catenin | Phenotypes | Pancreatic carcinoma | Molecular modelling | Diagnostic systems | Thyroid gland | Mutation | Neoplasms | Thyroid | Tumors
Pathology | Acinar cell carcinoma | Thyroid-like | Medicine & Public Health | Morphology | Differential diagnosis | Pancreas | β-catenin | Phenotypes | Pancreatic carcinoma | Molecular modelling | Diagnostic systems | Thyroid gland | Mutation | Neoplasms | Thyroid | Tumors
Journal Article
The Journal of Pathology, ISSN 0022-3417, 09/2016, Volume 240, Issue 1, pp. 3 - 14
The Hippo effector YAP has recently been identified as a potent driver of embryonal rhabdomyosarcoma (ERMS). Most reports suggest that the YAP paralogue TAZ...
WWTR1 | myoblasts | Hippo pathway | TAZ | embryonal rhabdomyosarcoma | TRANSCRIPTION FACTORS | STEM-CELLS | SOFT-TISSUE SARCOMAS | PROTEIN | YAP | PATHOLOGY | BREAST-CANCER | MUSCLE SATELLITE CELLS | ONCOLOGY | PATHWAY | ALVEOLAR RHABDOMYOSARCOMA | SKELETAL | Prognosis | Tissue Array Analysis | Humans | Rhabdomyosarcoma - metabolism | Cell Proliferation - physiology | Rhabdomyosarcoma - pathology | Survival Rate | Intracellular Signaling Peptides and Proteins - metabolism | Myoblasts - pathology | Cell Transformation, Neoplastic - metabolism | Myoblasts - metabolism | Animals | Cell Transformation, Neoplastic - genetics | Cell Line, Tumor | Mice | Rhabdomyosarcoma - genetics | Cell Transformation, Neoplastic - pathology | Intracellular Signaling Peptides and Proteins - genetics | Rhabdomyosarcoma - mortality | Immunohistochemistry | Muscles | Physiological aspects | Analysis | Stem cells | Original Papers | Original Paper
WWTR1 | myoblasts | Hippo pathway | TAZ | embryonal rhabdomyosarcoma | TRANSCRIPTION FACTORS | STEM-CELLS | SOFT-TISSUE SARCOMAS | PROTEIN | YAP | PATHOLOGY | BREAST-CANCER | MUSCLE SATELLITE CELLS | ONCOLOGY | PATHWAY | ALVEOLAR RHABDOMYOSARCOMA | SKELETAL | Prognosis | Tissue Array Analysis | Humans | Rhabdomyosarcoma - metabolism | Cell Proliferation - physiology | Rhabdomyosarcoma - pathology | Survival Rate | Intracellular Signaling Peptides and Proteins - metabolism | Myoblasts - pathology | Cell Transformation, Neoplastic - metabolism | Myoblasts - metabolism | Animals | Cell Transformation, Neoplastic - genetics | Cell Line, Tumor | Mice | Rhabdomyosarcoma - genetics | Cell Transformation, Neoplastic - pathology | Intracellular Signaling Peptides and Proteins - genetics | Rhabdomyosarcoma - mortality | Immunohistochemistry | Muscles | Physiological aspects | Analysis | Stem cells | Original Papers | Original Paper
Journal Article
Cell Reports, ISSN 2211-1247, 10/2012, Volume 2, Issue 4, pp. 855 - 865
Clericuzio-type poikiloderma with neutropenia (PN) is a rare genodermatosis associated with mutations in the C16orf57 gene, which codes for the uncharacterized...
IN-VITRO | 3' END | POLYMERASE-III TRANSCRIPTS | LUPUS ANTIGEN-LA | CLERICUZIO-TYPE POIKILODERMA | SIGNAL RECOGNITION PARTICLE | RECYCLING FACTOR | SM-LIKE PROTEINS | RIBONUCLEOPROTEIN-PARTICLES | SCHIZOSACCHAROMYCES-POMBE | CELL BIOLOGY | Recombinant Proteins - metabolism | Cell Line | Phosphoric Diester Hydrolases - metabolism | Neutropenia - metabolism | Humans | Exonucleases - deficiency | Phosphoric Diester Hydrolases - genetics | Recombinant Proteins - genetics | Ribonucleoprotein, U4-U6 Small Nuclear - metabolism | Schizosaccharomyces - metabolism | RNA Splicing | Skin Abnormalities - metabolism | Exonucleases - genetics | Neutropenia - pathology | Schizosaccharomyces - enzymology | RNA, Small Nuclear - metabolism | Skin Abnormalities - pathology | Exonucleases - metabolism
IN-VITRO | 3' END | POLYMERASE-III TRANSCRIPTS | LUPUS ANTIGEN-LA | CLERICUZIO-TYPE POIKILODERMA | SIGNAL RECOGNITION PARTICLE | RECYCLING FACTOR | SM-LIKE PROTEINS | RIBONUCLEOPROTEIN-PARTICLES | SCHIZOSACCHAROMYCES-POMBE | CELL BIOLOGY | Recombinant Proteins - metabolism | Cell Line | Phosphoric Diester Hydrolases - metabolism | Neutropenia - metabolism | Humans | Exonucleases - deficiency | Phosphoric Diester Hydrolases - genetics | Recombinant Proteins - genetics | Ribonucleoprotein, U4-U6 Small Nuclear - metabolism | Schizosaccharomyces - metabolism | RNA Splicing | Skin Abnormalities - metabolism | Exonucleases - genetics | Neutropenia - pathology | Schizosaccharomyces - enzymology | RNA, Small Nuclear - metabolism | Skin Abnormalities - pathology | Exonucleases - metabolism
Journal Article